Trials
Search / Trial NCT05643664

The Role of Artificial Intelligence in the Treatment of Abdominal Aortic Aneurysms

Launched by MESHALKIN RESEARCH INSTITUTE OF PATHOLOGY OF CIRCULATION · Dec 6, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

Aortic Aneyrism Artificial Intelligence "Safe" Zone Of Clamping Embolic Complications

ClinConnect Summary

Abdominal aortic aneurysm is a life-threatening disease, a formidable complication of which is an aneurysm rupture (Editor's Choice - European Society for Vascular Surgery). The main method of treating aneurysms is surgical reconstruction, including open or endovascular intervention ((ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms). Anatomical features of aneurysms and the presence of intraluminal thrombomass are among the criteria in deciding on the tactics of surgical treatment. These factors carry additional technical difficulties and ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with aneurysmal dilation of the abdominal aorta, who are shown surgery.
  • Patients who have agreed to participate in this study
  • Exclusion Criteria:
  • Chronic heart failure of functional class III -IV according to NYHA classification;
  • Chronic decompensated "pulmonary" heart;
  • Severe hepatic or renal insufficiency (bilirubin \>35 mmol/l, glomerular filtration rate \<60 ml/min);
  • Polyvalent drug allergy;
  • Malignant oncological diseases in the terminal stage with a predicted life span of up to 6 months;
  • Acute cerebrovascular accident;

About Meshalkin Research Institute Of Pathology Of Circulation

The Meshalkin Research Institute of Pathology of Circulation is a leading clinical research organization dedicated to advancing cardiovascular health through innovative research and development. Renowned for its commitment to scientific excellence, the institute specializes in studying the pathophysiology of circulatory diseases and developing novel therapeutic approaches. With a multidisciplinary team of experts, state-of-the-art facilities, and a robust infrastructure for clinical trials, the institute plays a pivotal role in translating research findings into practical solutions that enhance patient outcomes and contribute to the global understanding of cardiovascular conditions.

Locations

Novosibirsk, , Russian Federation

Novosibirsk, , Russian Federation

Novosibirsk, , Russian Federation

Novosibirsk, Novosibirskaya Obl, Russian Federation

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials